Clinical trial
A Study of the Safety and Efficacy of Long-term Correction of Anemia With…
NCT00261521 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00261521 |
|---|---|
| Title | A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients |
| Official title | Double-blind Study to Assess the Impact of Normalization of Hemoglobin Compared to Partial Correction of Hemoglobin With EPREX/ERYPO on Left Ventricular Structure in Early Hemodialysis Patients (RWJ-22512) |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic, Anemia |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 596 |
| Start date | Feb 1, 2000 |
| Completion | May 1, 2003 |
| First posted | Dec 5, 2005 |
| Last update posted | Dec 3, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: